Incidence trends and mortality rates of gastric cancer in Israel

Gastric Cancer

Volumn 16, Issue 2, 2013, Pages 121-125

  Lavy, Ron ^a,d   Kapiev, Andronik ^a,d   Poluksht, Natan ^a,d   Halevy, Ariel ^a,d   Keinan Boker, Lital ^b,c  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c UNIVERSITY OF HAIFA   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Gastric cancer; Incidence; Mortality; Trends

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; ETHNIC DIFFERENCE; FEMALE; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; STOMACH CANCER; SURVIVAL TIME; TREND STUDY;

AGED; ARABS; FEMALE; HUMANS; ISRAEL; JEWS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 84880697273     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-012-0155-4     Document Type: Article

References (23)

1. Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy - Japan Clinical Oncology Group study 9501. J Clin Oncol. 2004;22:2767-73.
2. Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch Gastric Cancer Group trial. J Clin Oncol. 2004;22:2069-2077.
3. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19:1893-907.
4. Verdecchia A, Corazziari I, Gatta G, Lisi D, Faivre J, Forman D, et al. Explaining gastric cancer survival differences among European countries. Int J Cancer. 2004;109:737-41.
5. Schlansky B, Sonnenberg A. Explaining gastric cancer survival differences among European countries. Am J Gastroenterol. 2011;106:1978-85.
6. Imamura Y, Yoshimi I. Comparison of cancer mortality (stomach cancer) in five countries: France, Italy, Japan, UK and USA from the WHO Mortality Database (1960-2000). Jpn J Clin Oncol. 2005;35:103-5.
7. Deans C, Yeo MS, Soe MY, Shabbir A, Ti TK, So JB. Cancer of the gastric cardia is rising in incidence in an Asian population and is associated with adverse outcome. World J Surg. 2011;35:617-24.
8. Jézéquel J, Bessaguet C, Verveur C, Faycal J, Richert Z, Metges JP, et al. Trends in incidence, management, and survival of gastric and cardia carcinomas in the area of Finistere (France) between 1984 and 2003. Eur J Gastroenterol Hepatol. 2010;22:1412-9.
9. Rozen P, Liphshitz I, Barchana M. The changing epidemiology of upper gastrointestinal cancers in Israel: clinical and screening implications. Eur J Cancer Prev. 2009;18:191-8.
10. Engel LS, Chow WH, Vaughan TL. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003;95:1404-13.
11. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137-50.
12. Buffart TE, Louw M, van Grieken NC, Tijssen M, Carvalho B, Ylstra B, et al. Gastric cancers of Western European and African patients show different patterns of genomic instability. BMC Med Genomics. 2011;4:7.
13. Sugai T, Habano W, Uesugi N, Jao YF, Nakamura S, Abe K, et al. Three independent genetic profiles based on mucin expression in early differentiated-type gastric cancers: a new concept of genetic carcinogenesis of early differentiated-type adenocarcinomas. Mod Pathol. 2004;17:1223-34.
14. Dreznik A, Purim O, Idelevich E, Kundel Y, Sulkes J, Sulkes A, et al. Gastric cancer: biology and clinical manifestations in Israel. J Surg Oncol. 2011;105:316-22. doi: 10.1002/jso.22078.
15. Jung KW, Park S, Kong HJ, Won YJ, Boo YK, Shin HR, et al. Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci. 2010;25:1113-21.
16. Keinan-Boker L, Noyman N, Chinich A, Green MS, Nitzan-Kaluski D. Overweight and obesity prevalence in Israel: findings of the first national health and nutrition survey (MABAT). Isr Med Assoc J. 2005;7:219-23.
17. Zidan J, Sikorsky N, Basher W, Sharabi A, Friedman E, Steiner M. Differences in pathological and clinical features of breast cancer in Arab as compared to Jewish women in Northern Israel. Int J Cancer 2011. doi: 10.1002/ijc.26431.
18. Ghaffari SR, Rafati M, Sabokbar T, Dastan J. A novel truncating mutation in the E-cadherin gene in the first Iranian family with hereditary diffuse gastric cancer. Eur J Surg Oncol. 2010;36:559-62.
19. Marie MA, Altahir IE. Relationship between the extent of DNA damage and gastritis in normal and Helicobacter pylori-infected patients. Gut Liver. 2011;5:315-20.
20. Gilboa S, Gabay G, Zamir D, Zeev A, Novis B. Helicobacter pylori infection in rural settlements (Kibbutzim) in Israel. Int J Epidemiol. 1995;24:232-7.
21. Rabin I, Chikman B, Lavy R, Poluksht N, Halpern Z, Wassermann I, et al. The accuracy of sentinel node mapping according to T stage in patients with gastric cancer. Gastric Cancer. 2010;13:30-5.
22. Strong VE, Song KY, Park CH, Jacks LM, Gonen M, Shah M, et al. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg. 2010;251:640-6.
23. Shin A, Kim J, Park S. Gastric cancer epidemiology in Korea. J Gastric Cancer. 2011;11:135-40.